» Articles » PMID: 25971390

Endogenous IgG Hypogammaglobulinaemia in Critically Ill Adults with Sepsis: Systematic Review and Meta-analysis

Overview
Specialty Critical Care
Date 2015 May 15
PMID 25971390
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Plasma immunoglobulin concentrations are acutely altered in critically ill patients with sepsis. However, the association between immunoglobulin levels on the day of sepsis diagnosis and subsequent mortality is inconsistent.

Methods: Systematic review of studies that report immunoglobulin measurements and mortality among adults with sepsis managed in a critical care setting. Fixed and random effect meta-analyses were conducted using low IgG levels as primary exposure and acute mortality as the primary outcome. Both variables were used as defined in individual studies.

Results: The prevalence of a low immunoglobulin G (IgG) concentration on the day of sepsis diagnosis was variable [58.3% (IQR 38.4-65.5%)]. Three cut-off points (6.1, 6.5 and 8.7 g/L) were used to define the lower limit of IgG concentrations in the included studies. A subnormal IgG level on the day of sepsis diagnosis was not associated with an increased risk of death in adult patients with severe sepsis and/or septic shock by both fixed and random effect meta-analysis (OR [95% CI] 1.32 [0.93-1.87] and 1.48 [0.78-2.81], respectively).

Conclusions: This systematic review identifies studies of limited quality reporting heterogeneous sepsis cohorts with varying lower limits of normal for IgG. Although our data suggest that a subnormal IgG measurement on the day of sepsis diagnosis does not identify a subgroup of patients with a higher risk of death, further studies are needed to confirm or refute this finding, and whether optimal cut-offs and time windows can be defined for IgG measurement. This would determine whether patients receiving intravenous immunoglobulin therapy for sepsis could be stratified using IgG levels.

Citing Articles

Intravenous immunoglobulin for mortality and inflammatory status in patients with sepsis: a retrospective database study.

Takano H, Kanda N, Wakimoto Y, Ohbe H, Nakamura K Front Immunol. 2025; 15:1511481.

PMID: 39885983 PMC: 11779611. DOI: 10.3389/fimmu.2024.1511481.


Impact of different pathogen classes on the serum -glycome in septic shock.

Torpy H, Chau T, Chatterjee S, Chernykh A, Torpy D, Meyer E BBA Adv. 2025; 7:100138.

PMID: 39877544 PMC: 11773048. DOI: 10.1016/j.bbadva.2025.100138.


Longitudinal assessment of immunoglobulin response and disease progression in critically ill patients with community acquired pneumonia.

Rademaker E, Vernooij L, van der Poll T, Bonten M, Leavis H, Cremer O Crit Care. 2024; 28(1):405.

PMID: 39639324 PMC: 11622494. DOI: 10.1186/s13054-024-05197-3.


Diagnostic and prognostic significance of apelin-13, APJ for sepsis in the emergency department: A prospective study.

Wang M, Gao Q, Guo S Heliyon. 2024; 10(7):e28620.

PMID: 38590887 PMC: 11000005. DOI: 10.1016/j.heliyon.2024.e28620.


Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options.

Pei F, Gu B, Miao S, Guan X, Wu J Chin J Traumatol. 2023; 27(2):63-70.

PMID: 38040590 PMC: 11075145. DOI: 10.1016/j.cjtee.2023.11.001.


References
1.
. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

2.
Boomer J, Shuherk-Shaffer J, Hotchkiss R, Green J . A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care. 2012; 16(3):R112. PMC: 3580670. DOI: 10.1186/cc11404. View

3.
Inoue S, Suzuki-Utsunomiya K, Okada Y, Taira T, Iida Y, Miura N . Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med. 2013; 41(3):810-9. DOI: 10.1097/CCM.0b013e318274645f. View

4.
Buyse M, Sargent D, Grothey A, Matheson A, De Gramont A . Biomarkers and surrogate end points--the challenge of statistical validation. Nat Rev Clin Oncol. 2010; 7(6):309-17. DOI: 10.1038/nrclinonc.2010.43. View

5.
Bermejo-Martin J, Rodriguez-Fernandez A, Herran-Monge R, Andaluz-Ojeda D, Muriel-Bombin A, Merino P . Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014; 276(4):404-12. DOI: 10.1111/joim.12265. View